- Home
- UHAL vs ICLR Comparison
UHAL vs ICLR Comparison
Compare UHAL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UHAL | ICLR |
|---|---|---|
| Founded | 1945 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 9.3B |
| IPO Year | 1994 | 2001 |
Fundamental Metrics
Financial Performance| Metric | UHAL | ICLR |
|---|---|---|
| Price | $71.39 | $172.39 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $178.62 |
| AVG Volume (30 Days) | 144.1K | ★ 805.3K |
| Earning Date | 05-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $6,037,819,000.00 | N/A |
| Revenue This Year | $5.89 | N/A |
| Revenue Next Year | $4.41 | N/A |
| P/E Ratio | $78.63 | ★ $12.91 |
| Revenue Growth | ★ 3.59 | N/A |
| 52 Week Low | $41.95 | $66.57 |
| 52 Week High | $76.45 | $203.91 |
Technical Indicators
Market Signals| Indicator | UHAL | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 48.14 | 57.57 |
| Support Level | $69.98 | $172.65 |
| Resistance Level | $72.95 | $188.49 |
| Average True Range (ATR) | 1.95 | 6.78 |
| MACD | -0.63 | 0.57 |
| Stochastic Oscillator | 7.40 | 73.21 |
Price Performance
Historical ComparisonAbout UHAL U-Haul Holding Company
U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.
About ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.